Traceable clonal culture and chemodrug assay of heterogeneous prostate carcinoma PC3 cells in microfluidic single cell array chips

Jaehoon Chung, Patrick N. Ingram, Tom Bersano-Begey, Euisik Yoon

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Cancer heterogeneity has received considerable attention for its role in tumor initiation and progression, and its implication for diagnostics and therapeutics in the clinic. To facilitate a cellular heterogeneity study in a low cost and highly efficient manner, we present a microfluidic platform that allows traceable clonal culture and characterization. The platform captures single cells into a microwell array and cultures them for clonal expansion, subsequently allowing on-chip characterization of clonal phenotype and response against drug treatments. Using a heterogeneous prostate cancer model, the PC3 cell line, we verified our prototype, identifying three different sub-phenotypes and correlating their clonal drug responsiveness to cell phenotype.

Original languageEnglish
Article number056502
JournalBiomicrofluidics
Volume8
Issue number6
DOIs
Publication statusPublished - 2014 Nov 14

Fingerprint

phenotype
Microfluidics
Assays
cancer
chips
Drug therapy
drugs
platforms
cells
Tumors
Cells
cultured cells
progressions
tumors
prototypes
Pharmaceutical Preparations
Costs
expansion

All Science Journal Classification (ASJC) codes

  • Biomedical Engineering
  • Materials Science(all)
  • Condensed Matter Physics
  • Fluid Flow and Transfer Processes
  • Colloid and Surface Chemistry

Cite this

@article{0b9eaef33a0e4a3fbe65fe12c07c6116,
title = "Traceable clonal culture and chemodrug assay of heterogeneous prostate carcinoma PC3 cells in microfluidic single cell array chips",
abstract = "Cancer heterogeneity has received considerable attention for its role in tumor initiation and progression, and its implication for diagnostics and therapeutics in the clinic. To facilitate a cellular heterogeneity study in a low cost and highly efficient manner, we present a microfluidic platform that allows traceable clonal culture and characterization. The platform captures single cells into a microwell array and cultures them for clonal expansion, subsequently allowing on-chip characterization of clonal phenotype and response against drug treatments. Using a heterogeneous prostate cancer model, the PC3 cell line, we verified our prototype, identifying three different sub-phenotypes and correlating their clonal drug responsiveness to cell phenotype.",
author = "Jaehoon Chung and Ingram, {Patrick N.} and Tom Bersano-Begey and Euisik Yoon",
year = "2014",
month = "11",
day = "14",
doi = "10.1063/1.4900823",
language = "English",
volume = "8",
journal = "Biomicrofluidics",
issn = "1932-1058",
publisher = "American Institute of Physics Publising LLC",
number = "6",

}

Traceable clonal culture and chemodrug assay of heterogeneous prostate carcinoma PC3 cells in microfluidic single cell array chips. / Chung, Jaehoon; Ingram, Patrick N.; Bersano-Begey, Tom; Yoon, Euisik.

In: Biomicrofluidics, Vol. 8, No. 6, 056502, 14.11.2014.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Traceable clonal culture and chemodrug assay of heterogeneous prostate carcinoma PC3 cells in microfluidic single cell array chips

AU - Chung, Jaehoon

AU - Ingram, Patrick N.

AU - Bersano-Begey, Tom

AU - Yoon, Euisik

PY - 2014/11/14

Y1 - 2014/11/14

N2 - Cancer heterogeneity has received considerable attention for its role in tumor initiation and progression, and its implication for diagnostics and therapeutics in the clinic. To facilitate a cellular heterogeneity study in a low cost and highly efficient manner, we present a microfluidic platform that allows traceable clonal culture and characterization. The platform captures single cells into a microwell array and cultures them for clonal expansion, subsequently allowing on-chip characterization of clonal phenotype and response against drug treatments. Using a heterogeneous prostate cancer model, the PC3 cell line, we verified our prototype, identifying three different sub-phenotypes and correlating their clonal drug responsiveness to cell phenotype.

AB - Cancer heterogeneity has received considerable attention for its role in tumor initiation and progression, and its implication for diagnostics and therapeutics in the clinic. To facilitate a cellular heterogeneity study in a low cost and highly efficient manner, we present a microfluidic platform that allows traceable clonal culture and characterization. The platform captures single cells into a microwell array and cultures them for clonal expansion, subsequently allowing on-chip characterization of clonal phenotype and response against drug treatments. Using a heterogeneous prostate cancer model, the PC3 cell line, we verified our prototype, identifying three different sub-phenotypes and correlating their clonal drug responsiveness to cell phenotype.

UR - http://www.scopus.com/inward/record.url?scp=84911382012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911382012&partnerID=8YFLogxK

U2 - 10.1063/1.4900823

DO - 10.1063/1.4900823

M3 - Article

AN - SCOPUS:84911382012

VL - 8

JO - Biomicrofluidics

JF - Biomicrofluidics

SN - 1932-1058

IS - 6

M1 - 056502

ER -